Searched for
PUBLIC MARKET ACCESS FOR BIOTECH
Thanks, Trump-ji for the push we neededUS attempts to control advanced AI model exports face challenges. This may push nations like India to develop their own AI capabilities. In...- India known as nation with world's largest healthcare programme: PM ModiPrime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such ...
- IPO Calendar: Two companies to launch public offers in a quiet week for the primary marketThe IPO market will see limited activity next week, with only two SME issues, Liotech Industries and Leapfrog Engineering, opening on June ...
- Sebi plans to ease KYC rules for FPIs, offer more clarity to global capitalIndia’s financial watchdog, Sebi, is gearing up to make the investment terrain more inviting for foreign investors by reforming the Know Yo...
- Maharashtra’s Ready Reckoner revamp may align valuations with market realitiesIn a bold move, Maharashtra is gearing up to implement micro-zoning alongside tailored Ready Reckoner rates, a shift designed to refine pro...
- World's first trillionaire: SpaceX premium debut briefly hands Elon Musk historic statusElon Musk briefly touched a trillion-dollar net worth as SpaceX shares surged on its Wall Street debut, though his wealth later settled bel...
- Sebi to review delisting framework to ease exitsIndia's market regulator, SEBI, plans to review its delisting rules. This move aims to simplify capital market processes for businesses. SE...
- India's agriculture and water tech startups gain momentum, sustainability in focus: NasscomIndia's agri and water tech deeptech ecosystem is gaining momentum around commercialization as per a statement by Nasscom. These sectors st...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- FX swap window may spur PSU rush for overseas loansPublic sector units like PFC, REC, and NaBFID are poised to increase their External Commercial Borrowings (ECBs) to leverage the RBI's 1.5%...
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
- Binance extends pre-IPO perpetual lineup to OpenAI after SpaceX successBinance is democratizing pre-IPO price discovery with its new Pre-IPO Perpetual Contracts. These products allow eligible users to speculate...
- Crypto crash: Where do Bitcoin and Ether stand after the historic crash?The prices of two other tokens, Ethereum and Solana, also rose on Monday, gaining 3.25% and 4.18%, respectively. Ethereum, the second-large...
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
- SpaceX IPO gets Cryptocurrency touch. Here's howSpaceX, which began its roadshow last week, has drawn investor demand of about $150 billion for its IPO, about double the $75 billion it is...
- Easier FPI access to equity, debt marketsIn a strategic bid to entice foreign investors, India is simplifying tax regulations on select securities. This initiative is designed to b...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
Load More
